Directory

>

Dongxing Zha

avatar

Dongxing Zha

CTO, TCR Discovery and Engineering at Alloy Therapeutics | Founder and CEO at Keyway TCR Discovery | Alloy Therapeutics, Inc.

Waltham, Massachusetts, United States

View contact details (it's free)

Dongxing Zha

Summary

Dongxing Zha is a distinguished leader in drug development, specializing in immune-oncology and biologics. As the CTO at Alloy Therapeutics and the founder of Keyway TCR Discovery, he drives innovative research aimed at creating effective anti-cancer therapies. His leadership of the ORBIT platform at MD Anderson Cancer Center showcases his commitment to collaborative science and patient-centered drug development. With a rich academic background, including a PhD in Microbiology, Dongxing has a proven track record in biotechnology, specifically in antibody development and cellular therapies. He has held significant roles at prestigious institutions like Merck and the Chinese Academy of Sciences, reflecting his deep expertise in life sciences and molecular biology. Dongxing's work not only advances scientific understanding but also aims to translate discoveries into real-world applications for cancer treatment.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Immigrant

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Startup Experience

Dongxing Zha

Work Experience

company logo

CTO, TCR Discovery and Engineering at Alloy Therapeutics | Founder and CEO at Keyway TCR Discovery at

Alloy Therapeutics, Inc.

September 2021 - Present

company logo

Institute Head, ORBIT Platform at

The University of Texas M D Anderson Cancer Center

June 2019 - August 2021

company logo

Institute Associate Director at

The University of Texas M D Anderson Cancer Center

September 2017 - June 2019

company logo

Institute Group Leader at

The University of Texas M D Anderson Cancer Center

May 2014 - August 2017

company logo

Research Fellow and Group Leader at

Merck

May 2006 - May 2014

💼

Senior Research Scientist at

GlycoFi

September 2002 - May 2006

💼

Postdoctoral Fellow at

Max-Planck-Institut fur Kohlenforschung

May 1999 - September 2002

company logo

Research Scientist at

Novo Nordisk

January 1998 - May 1999

company logo

Scientist at

Chinese Academy Of Sciences

January 1997 - January 1998

Logos provided by Logo.dev

Dongxing Zha

Education

Huazhong Agricultural University, Doctor Of Philosophy - Phd

Anhui Normal University , Bachelor Of Science - Bs

Frequently Asked Questions about Dongxing Zha

What is Dongxing Zha email address?

Dongxing Zha's primary email address is ************@alloytx.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Dongxing Zha work for?

Dongxing Zha is a CTO, TCR Discovery and Engineering at Alloy Therapeutics | Founder and CEO at Keyway TCR Discovery at Alloy Therapeutics, Inc., a company specializing in Commercial physical research.

Where Dongxing Zha graduated from?

Dongxing Zha holds a degree in Microbiology, General from Huazhong Agricultural University.

How can I directly contact Dongxing Zha?

To contact Dongxing Zha directly, you can use the email address ************@alloytx.com. Complete contact information is available upon registration with Muraena.

Is Dongxing Zha an immigrant?

Yes, Dongxing Zha is an immigrant and currently based in United States

Who is Dongxing Zha?

Dongxing Zha is a distinguished leader in drug development, specializing in immune-oncology and biologics. As the CTO at Alloy Therapeutics and the founder of Keyway TCR Discovery, he drives innovative research aimed at creating effective anti-cancer therapies. His leadership of the ORBIT platform at MD Anderson Cancer Center showcases his commitment to collaborative science and patient-centered drug development. With a rich academic background, including a PhD in Microbiology, Dongxing has a proven track record in biotechnology, specifically in antibody development and cellular therapies. He has held significant roles at prestigious institutions like Merck and the Chinese Academy of Sciences, reflecting his deep expertise in life sciences and molecular biology. Dongxing's work not only advances scientific understanding but also aims to translate discoveries into real-world applications for cancer treatment.

Dongxing`s contact details

mail

************@alloytx.com

****@mdanderson.org

Colleagues

avatar
Mike Schmidt

General Partner

avatar
Casey Matthews

Vice President of Daedamab Business Development

avatar
Heather Schwoebel

Harvard Business Review Advisory Council Member

avatar
John Lippincott

Senior Vice President Therapeutic Discovery Strategies

avatar
Zhiqian Lucy Liu

VP Head of Protein Science & Bioanalytics

View Contact details (it's free)
Request Profile Removal